U.S. Food and Drug Administration approvals of life-changing, high-risk medical devices reportedly slowed to a 10-year low for the January to March period, as recent layoffs have reportedly had ...

President Trump’s newly announced tariff policy has done more than just push the stock markets deeper into correction territory — the sudden ...

Annual Meeting Clinical Trials Plenary Session, Sanofi presented data on tolebrutinib in patients with non-relapsing ...

Care providers and patients are now speaking out after a First Alert 4 investigation Monday revealed safety concerns with IV ...

If approved, LMTX has the potential to become the first orally available disease-modifying therapy (DMT) in the UK.

We recently published a list of 10 Stocks Under $10 that Will Triple. In this article, we are going to take a look at where ...

ClearBridge Investments, an investment management company, released its “ClearBridge Value Strategy” first quarter 2025 ...

Using approved MS drug Copaxone during pregnancy or breastfeeding does not appear to raise the risk of problems for the child ...

A retrospective study showed that either folate receptor alpha or B7-H4 was expressed in more than 80% of endometrial cancers ...

New Report Highlights the Science Behind Nerve Freedom-A Natural Supplement Aimed at Supporting Long-Term Nerve Health ...